Serum reagent kit 07M5275A

plasmadiagnosticchemiluminescence

The 17α-hydroxyprogesterone (17αOHP) Chemiluminescence Immunoassay kit is intended for the measurement of 17αOHP concentration in human serum or plasma. Usage Statement FDA cleared for In Vitro Diagnostic (IVD) use in the United States. CE Marked for IVD use outside the United States. Analyte / Target - 17OHP (17 alpha hydroxyprogesterone) Base Catalog Number - M5275A Diagnostic Platforms - ChLIA Diagnostic Solutions - Endocrinology Disease Screened - 17OHP Evaluation - Quantitative Pack Size - 1 96 Wells Sample Type - Plasma, Serum Sample Volume - 25 µL Sensitivity - 0.040 ng/mL Species Reactivity - Human Usage Statement - FDA cleared for In Vitro Diagnostic (IVD) use in the United States. CE Marked for IVD use outside the United States.